Bridge-It trial—a step towards better contraception services

At the 4-month follow-up, use of effective (hormonal or intrauterine) contraception (primary outcome measure) was 20·1% higher (95% CI 5·2–35·0) in the intervention group (mean 58·4%, 48·6–68·2) than the control group (mean 40·5%, 29·7–51·3; p=0·011).1 Of 636 participants, 4-month follow-up data were available for 406 (64%) women: 198 (63%) of 315 in the intervention group versus 208 (65%) of 318 in the control group. [...]providing the progestogen-only pill in a convenient way would most likely increase uptake, particularly because the method is controlled by the user and is easy to start and stop (25% of those in the intervention group stopped using the progestogen-only pill because of side-effects).1 Details about the experiences of diverse social groups are largely absent from the trial report; ethnicity and parity are mentioned briefly without explanation. Researchers, policy makers, and service providers should work with communities to identify and codesign more interventions to meet people's needs.6 Future efforts need to include the voices of people who use and those who do not use existing services, and take an intersectional approach to identify and address contraceptive needs that are likely to differ depending on characteristics such as age, relationship type, gender identity, disability, cultural background, employment status, and the ability to attend clinics.